Episode 18: Our Greatest Challenge

Peter 0:13
Hi, and welcome back to the Gastronauts Podcast. My name is Peter and I’ll be your host. As many of you know, here at Gastronauts, we are committed to exploring communication throughout the body, with a particular focus on the crosstalk between gut and brain. We invite speakers across the globe to share both their research and their life journeys. So come join me as we explore the steps that go into shaping a scientist on the Gastronauts Podcast.

Today, we have a panel of four incredible rising stars in their respective fields. Dr. Kara Marshall is a postdoctoral fellow at Scripps Research in San Diego, California. She studies the nerves that control our bladder. And recently she found out that Piezo2, a molecular channel that senses mechanical forces, in fact works to control our peeing.

Dr. Kara Marshall 1:23
Thanks.

Peter 1:24
Dr. Dafni Hadjieconomou is a postdoctoral fellow at the Imperial College of London. She studies how neural circuits in the gut of a fly, or these enteric neurons, are altered during pregnancy. And she has found that these enteric neurons are key to increasing food intake of the mother and enhancing reproductive success.

Dr. Dafni Hadjieconomou 1:45
Thank you.

Peter 1:46
Dr. Marcelo Zimmer is a postdoctoral fellow at Yale and the Federal University of Rio. He studies how certain neurons in the brain of a neonatal mouse respond to maternal separation. Activation of these neurons induces ultrasonic vocalizations or USVs to encourage the mother to return to the pup, so she can continue providing care.

Dr. Marcelo Zimmer 2:08
Thank you.

Peter 2:09
And lastly, Dr. Yuuki Obata, is a postdoctoral fellow at the Crick Institute of London. He studies how bacteria in our gut talk to neurons in our gut to change intestinal motility and control the rate at which food moves through our intestinal tract.

Dr. Yuuki Obata 2:25
Thank you.

Peter 2:26
Science is a global endeavor, and we can tell from this conference with people calling in from all over the world. It’s really great seeing so many excited and engaged scientists, but it has to start small- from the groups with the people that you work with, with the mentorship that you provide different people who are just, you know, trying their first time in science. Now that you all are transitioning from the postdoc to perhaps an independent investigator, what mentoring principles Do you guys hold? Or what are you looking for in a trainee?

Dr. Kara Marshall 2:56
I mean, I’ll start I mean, I’m not a PI yet. But I actually think about it a lot. Because this is the huge jump that we have to make, right? We go from being bench scientists to all of a sudden being mentors, and it’s a completely different job. So I think about it a lot now to be like, how can I prepare and do a good job. And I think that one of the things that I’ve learned the most is that, you know, just like anything else, it is a skill. And unfortunately, I think a lot of people don’t consider that as you know, a skill that they can build and should try to build. And like, there is known information out there about how to be a good manager, and scientists are not concerned with that, right? Because we’re all excited about the science. And so we all focus on just like let’s get the science done. But um, yeah, as a PI, like, you have to manage people, that’s kind of your number one job. And so I think that, you know, I was talking to someone not too long ago about how she actually just hired someone in the business world to teach her how to hire people, and how to manage people, because it’s like, these are not unknown things, and scientists just kind of like, wing it, you know, and ends up being it ends up making for really, sometimes unprofessional environments, and then also environments where really, people aren’t doing their best science because they don’t feel like they’re being managed appropriately. And so I don’t know, I guess just having a growth mindset. That’s kind of cheesy, but it’s true, right? Like, you can learn these things like there’s, you know, data out there. And so trying to actually just learn the skills that are needed to manage people, I think, and just listening to people and actually really listening to what each individual needs and not just trying to one, one fits all solution. That’s my goal.

Dr. Dafni Hadjieconomou 4:29
Yeah, I would really also second that, I guess, for me, with a little bit of mentorship that I have given and what I have experienced, I think this the you should never think that one fits all is the take home message for me. You know, because I have also tried to be the mentor I wanted but this doesn’t always work. So I guess it’s going to be a lot of trial and error and there will be biases, you know, for for the mentor you wanted to have always or you had and you really loved or you had an you really hated. And I guess this is why what you’re saying care there is is important, perhaps we have to really work on this as a muscle that has to grow actively. And I guess also, again, get information as we do with everything else get information from people that have done it a while back. And we respect for instance, I guess this is how I plan to do it.

Dr. Marcelo Zimmer 5:25
Yeah, I definitely agree with Dafni, I think we need to learn from people who are already in the lab mentoring people, because as Kara said, we don’t know how to manage people, and then we suddenly we are being mentored to mentor people. So it’s a rapid transition. As a mentor, if I’ll be a mentor, one day, I’ll try to use my experience during my PhD, to do the same that I that I received while I was a practitioner to the students. And I think one of the best ways to do science is being always highly motivated. You need to motivate your students, we know that motivation plays a critical role in continuing science, because we’re going to fail all the time, failure will be a part of the process during our studies. So I think having a highly motivated mentor, they allow us to do anything that you wanted. I think that is the key, in my opinion.

Dr. Yuuki Obata 6:18
Yeah, I think I was very lucky to have great mentors. So what I learn from them in my future career. And also I have experience to teach some students in the lab, and they’re also great, and they really like science and think about trying to addressing the question not just for the job. So then the very good relationship was built. So yeah, that’s I think that depends on the motivation, the science and yeah.

Peter 7:02
We have a question from Lihua.

Audience 7:04
Dr. Zimmer, my question is: early life isolation that used in your model, your mouse model have been known to induce irritable bowel syndrome in the mouse. I’m just conscious curious, like, whether you finding has anything that related to the symptoms that developed in mouse models later in their life, like, increase of visceral sensitivity, and difference in the enteric motility and whether you’re finding will have anything connection to that

Dr. Marcelo Zimmer 7:39
Thanks for the great question. It’s something that people usually ask for us, if you follow the facts of the material separation later in life, and we never follow actually. So I don’t know. I don’t know if they actually they could be contributing for the development of the irritable bowel syndrome, but it’s definitely like at a very important question to try to evaluate the future for sure. Thanks for the question.

Peter 8:04
Next, we have Julia Davis.

Audience 8:06
I’m calling him from Boston. And I just had kind of like a more general question. Earlier this week, I was just looking at some literature and kind of like the gut brain axis and its relationship with neuro-inflammation. And I was wondering, like, if any of you kind of have thoughts on that, or like the mechanisms for how that might influence other disorders like delirium, or Alzheimer’s disease, which are often linked to neuro inflammation, and just kind of like, if you think that there is kind of value in going down that path, and seeing if there’s the microbiome does can play a role in our understanding of those diseases that are still kind of a little bit unclear.

Dr. Dafni Hadjieconomou 8:41
I think it’s pretty exciting. And I guess we don’t have the tools perhaps, or the understanding yet on how this works exactly. But, you know, and this is what I sort of wanted to put out there with my introductory bit that is so complicated, because we just beginning to understand that this microbiome does a lot of very different things. And, you know, Yuuki presented one of these aspects, but I guess it’s out there that this is all regulated and there is a link for sure with with the brain, and then all of these disorders could be coming from the microbiome, and then they are linked directly to the brain or their local inflammation in the gut that then link looks back to the brain. And I guess all of them could have a little bit of that. And something we don’t quite understand yet. But sure, sure. Is it an exciting way forward to think about that?

Audience 9:43
Hey, everyone, my name is Maya Kaelberer. I’m at Duke University. So my question is actually for Dafni, and Yuuki: how’s the microbiome changing during pregnancy? And is it known if these changes are actually affected some of the food intake right so I’m assuming that pregnancy does a lot to the body. I’m just wondering does it change the microbiome? And can you actually change your food intake that way?

Dr. Dafni Hadjieconomou 10:06
Thank you. I think I’m gonna let Yuuki go first. I’m not a microbiome expert.

Dr. Yuuki Obata 10:13
I’m not sure about this. And we know maternal microbiota is very important for the development of the immune system and nervous system have in the offspring animal. But in this case, I’m not sure how pregnancy affected it. I can imagine there are many changes to hormonal change can affect the microbiome, but I don’t know.

Dr. Dafni Hadjieconomou 10:33
And if we take it back to the fly, I guess there there are differences in general, with the microbiome and the colonization, and so on, as surely when flies lay eggs, they do also lay a bit of anti-microbials. So there might be changes. Sure. We don’t know if these do affect the way the flies eat? Not to my knowledge. I don’t know that. But yeah, very interesting question, Maya, for sure.

Peter 11:08
Yeah, I think it’s a really great question. And it made me think of, I guess, technological developments, and how we think about technology changing over time, and a lot of our studies are done really at a specific time point, or at a specific location, right? How do you expect your findings to translate across time or at different stages during development? I think each one of our talks today had a little bit of this theme, right? With Marcelo’s Agrp neurons having a different function early on in life. Dafni during reproduction, you have, you know, this innervation that has a differential effect. And Kara, right, when you mentioned, specifically like these Piezo2 neurons and piezo and urinary issues happened primarily when we’re older. So I was curious as to, just to reiterate, like how you expect the findings that you have to translate across different times? Or is this something that you’re interested in moving forward?

Dr. Dafni Hadjieconomou 11:57
Yeah, absolutely. I think, you know, this audience is already already unique, that, you know, we do think of other bits of the other organs, not only one, like people normally really focus on one neuron in the brain or one year, in their favorite place, or, and here, we’re talking about inter organ signaling. But I think also, yes, absolutely. For me, the timing is a very important element, because we you look at this ms neuron that I described, and it’s very different after mating, animated female. And I have also seen that it’s, it’s quite different after different food in food to being presented with different dietary challenges, let’s say. So this is also what I plan to do, I plan to see what happens in different challenges internally, but also in different times. So developmental is one thing, and how that shapes its function in the adult, for instance, because now what I presented, you were specifically adult neurons, right, that were manipulated for a few hours in the adult body. And that’s the beauty again, of the fly. But you can do the manipulation the other way around and look later on what happens. So for me, absolutely.

Dr. Marcelo Zimmer 13:14
I think that one of the biggest reasons that I’m doing this research in infants is trying to understand how the new secrets which neural secrets involve, and which neural secrets regulating behavior, because what we know from the literature is that any type of early life stress in an infant, and we’re talking about many types of mammals, including humans, leads to long term consequences. So if you at least start to tracking which are the newest they are, they are sensitive, when the animals are isolated with animals are exposed by like stress, we can actually benefit us understand if the neighbors were involved in this long term consequences that we see when we isolate all the animal is exposed to like stress.

Dr. Yuuki Obata 13:58
Yes, time is a very important factor for for our system as well. Actually, we are recently interested in the effects of the time of the day in the in the physiology of the enteric nervous system. As you can imagine, it’s it has a circadian rhythm in the activity of chronic peristalsis. And also, the number and composition of microbiota shows circadian rhythm as well. So we we are actually interested in how changing their time affect the physiology. Of course, we also are interested in the developmental time period or embryonic stage. This is a very important topic to study.

Dr. Kara Marshall 14:44
Yeah, I kind of touched on it. I totally agree that given the role of aging and kind of how aging ends up corresponding with a lot of issues in the urinary tract, it’ll be interesting to see how these circuits change how the sensors change, and then Development here. I mean, both sides of the equation are really fascinating.

Audience 15:02
Hi, hello, I’m Elaine Snell, I’m from London, does Piezo2 naturally diminish with age? And in which case, does that explain the high rate of urinary dysfunction in people of an older age group? And would that be or is it already a target for for treatment or strategy for treatment to kind of replace that if that’s possible?

Dr. Kara Marshall 15:25
Excellent question. And it’s something that I can’t answer directly, because we don’t know if the protein expression changes during age in the system. But I’ll answer it from the perspective of what we know about the skin because we know a lot more about touch receptors in the skin, which are also mechano-sensitive. And we do know that with age people do lose these sensory neurons. So your innervation, density goes down, and you become less touch sensitive. And so it’s very possible that this happens internally as well. And again, I think that this is an entire area that could be really interesting to understand how internal innovation changes with age, and maybe it’s diminished in the same way that our skin innovation has diminished. And all of the sequela that come after that, right? You know, neuropathy, diabetic neuropathy, which of course, diabetes is very common, and that leads to degeneration of some of these, some of these innervation. And it could have, you know, similar effects in the skin as it does inside, so you might get all of the reflexes, all of the sensing, if that’s gone, you know, that could absolutely cause dysfunction. And so I don’t know yet, but there’s definitely a precedent for that in other organs. So it’d be interesting to see. And then as far as therapeutics, you know, I’m a big believer and understanding the basic science and molecules of how things work, give us targets. Right now, we don’t have good pharmacological tools to target this ion channel, in particular. It’s proving to be actually quite difficult, because unlike a lot of other ion channels, these respond to tension in the membrane. And so how do you make a drug that targets that- it’s not clear that we’re going to have great like a lock and key mechanism where we can get something to bind. And so that hasn’t been very easy to find so far. In the future, though, it would be wonderful if it could, because I sort of touched on in the beginning that this, this protein is involved in so many different sensory functions. And so it would be great to have a pharmacological tool. But you know, if not pharmacological, you know, maybe there’ll be something else, some sort of genetic tool, or even estimate stimulation protocols, or something that we could do to help in the future. It’d be really interesting.

Peter 17:21
Next, we have a question from Valentina.

Audience 17:24
I’m calling in from Boston. And I have a question for Kara. I was wondering if you looked at the role of sex hormones in your model. And if you think, or if you observed any differences in your knockouts between males and females. I guess I’m just wondering if sex hormones might potentially regulate Piezo2 and these different patterns for urination?

Dr. Kara Marshall 17:47
Yeah, that’s interesting. So I haven’t looked at this at all. But it’s an interesting question, because we do know that some of these lower urinary tract pathologies are very different between men and women in terms of what kinds of pathologies they get, and how they manifest. And part of this is simply anatomical, males have much longer urethra. So they’re less prone to say UTIs but then there are other problems that come with having a prostate. And so part of these anatomical differences kind of designate what the pathologies are later in life. So I haven’t looked at sex hormones in particular, but it’s also possible that kind of overlaid on top of the anatomy has some role. But I don’t know the answer to that yet. I will say that I did do full cohorts of males and females in all of my studies. And to the extent to which the responses are slightly different because of the anatomy. All of the other phenotypes were exactly the same. So I saw the same deficits in males and females, they saw the same remodeling. But again, you know, males, because they have, especially in mice, their ureters are so small and so long, that the coordination is particularly important for them to go. So I think the remodeling was maybe worse for them. But overall, it seemed like the result was the same in males and females. Thanks for the question.

Peter 18:57
Yeah, that’s interesting, this sex difference question reminded me of some of the things that Dafni talked about with the MS neurons. And I was wondering, do the sensory neurons of urinary control change during pregnancy? Like what are the parallels between the enteric nervous system and the bladder?

Dr. Kara Marshall 19:11
Yeah, I’d say that it’s all open. You know, I don’t know, I hadn’t really considered looking during pregnancy. But of course, that is a- that is a time of like, massive change. So it’d be interesting to know if some of the innovation changes to I don’t know.

Dr. Dafni Hadjieconomou 19:25
Yeah, I don’t know. This is why I thought, you know, it would be very interesting to see if the neurons change or the epithelium changes with both of them, and what happens at the molecular level, because, you know, somehow this body needs to cope. it undergoes under increasing pressure. And I guess in the mouse model, you might have more or less pups, and that also might change. So I think it’s very exciting to just have a look. Yeah, and I would imagine that there are changes, but then yeah.

Dr. Kara Marshall 19:59
I also wonder how different it is between mice and humans, given that humans are upright, and so much of that gravitational pull has a huge effect. And in mice, I wonder if I’m being this direction means that that is different. And you know, the the two horn of the uterus, maybe they actually are spared some of the issues that humans go through. I don’t know, though, be interesting to find out.

Peter 20:21
This is really interesting. Moving on, we have another question for Dafni. So the fly mid gut is like the primary site for food digestion & absorption, what is known about neuronal innervation in the fly mid gut? How are the enteric neurons affecting intestinal motility? absorption?

Dr. Dafni Hadjieconomou 20:40
Yeah, thank you. So not a lot was known. And the truth is that not a lot is known. So in fact, Irine’s lab really did bring home this. So she was one of the founders, I guess, in it, and there are enteric neurons and the fly. And the paper, the first paper of the lab described some of this innovation in our paper, the recent paper also gives a bit more information about the integration of the medical and especially the anteromedial, which is, I guess the question goes for that, where a lot of the digestion is happening now for the function. So we do know, for specific lineages, some of the aspects of the function that do go to the mid gut, and the neurons that I talked about today go to the mid gut, as well as the crop. And now for peristalsis, for the midgut. Specifically, I guess we don’t know exactly how they. So their motor, so the motor output is for specific types of neurons. If you talk completely paralyzed, of course, the gut. Yeah, there is a problem. But it’s just the beginning of this. So similar to the mammalian lineages, we did not we didn’t know so much about them, I guess, what is nice is that we can manipulate small subsystems of them and uncover what their function is.

Peter 22:05
Great- I actually had like a relatively broad question for all of you is really interesting seeing the different model systems that you all use. Marcelo, you mentioned that you’re planning to do some future work in guinea pigs, Dafni, you’ve been working flies; Kara, you’ve done some human studies, and Yuuki, you’re doing work in a nice. So I was wondering, how do you choose which animal system to use? And then in your future work do you plan on continuing to use the same animal models? Are you planning to diversify what systems you’re going to be studying?

Dr. Kara Marshall 22:32
I will say that it was actually a really fortunate thing that we were able to include the humans in the study with the mechanistic mouse models. And I think there was a bit of luck there, I mean, to have this group of patients was, we were incredibly fortunate because of course, you don’t always get that with any particular gene that you’re studying. So I would love to do more of that in the future. But I think it it sort of depends on, you know, wonderful collaborators, being open to open to working with us. And I think that that’s a general lesson in science, that if people are open to collaborating, especially across disciplines, like with clinicians, because of course, the science is very different, that the story becomes so much stronger. And so I mean, I would love it, if that could happen in the future again.

Dr. Dafni Hadjieconomou 23:13
I do plan to work on flies and, and actually collaborate or anything else. So my drive is really coming from basic discovery in basic science. So I think the fly is a powerful model for understanding genetics, and really basic mechanisms. And then the conservation of this, you know, other people that I can collaborate with can do in, in higher mammalian systems, let’s say that being the mouse or humans, for instance, I will be very excited to work with people along along the way. But my drive is really this basic mechanisms, and I plan to work on flies for the rest of it.

Dr. Marcelo Zimmer 23:57
I think, really the purpose of our long term goals. But I think as a scientist, we always try to contribute to the well being of the human being and to humans. But the reason I choose to move towards minipigs is that I’m really interested interested in the infant’s perspective of interaction with the mother. Whereas we know a lot of researchers in a lot of studies doing the maternal behavior in mice, right. So we don’t know much about how the infant’s they communicate how they how they interact the mother, most likely most because these infants they are born in a three show state, so they are really mature. So we cannot really evaluate the behavior of the infants during this first few days of life. Whereas the green epic the infant is born in precocious states, so the animals are much more active, much more mature. So using this animal model, I think we are able to at least understand better when do me think about your secrets that are involved in the infant direction to the mother.

Dr. Yuuki Obata 24:57
So for me, the reason I’m here using the mouse, so it’s just it’s very, very well organized, it’s very established model. But I’m also interested in the other other models, including a human, or even Hydra they, or zebrafish, because each each model has on advantage and disadvantage, a bad combination these studies helps us to understand different aspects of physiology by using different techniques.

Peter 25:28
Yeah, it’s really great to hear all of your perspectives on the pros and cons of different model systems, how sometimes it’s due to collaboration has sometimes it’s due to chance.

Audience 25:38
Hello, I’m yeah, I’m Alistair McDonald. And I’m calling from Exeter in the UK. And my question is for Dr. Marshall, I’m interested to know how much of the Piezo2 pressure sensing is, is mediating intrinsic kind of bladder or spinal to bladder versus integrating top down control from the brain. So you have some looks like full urination in the middle of the cage. So maybe properly initiated, but just at the wrong point, how much of that sensory detection is useful for the brain?

Dr. Kara Marshall 26:09
Yeah, so all of the functions I was showing with regard to cystometry and the urethral reflexes, these would be spinal reflexes, right? So these are mediated by spinal pathways. And, you know, we think the sensory neurons, of course, are directly conveying information, the bladder goes to the urethra, and the urethra actually goes to the bladder. So you know, you want when your bladder is ready to contract, you want it to contract against a relaxed urethra. And then similarly, when your rethrow has fluid flow go through, it sends signals back to increase bladder contraction. So these kind of are classical reflexes that have been defined for a while. So we think that definitely Piezo2 sensory neurons are mediating the initiation of these reflexes. But we haven’t looked at all as to you know, how this sensory information is integrated in Barrington’s nucleus, which is the nucleus that controls top down urination. And I’m so glad you brought it up, because it is really important. And in fact, people who study urination, primarily study these brain mechanisms that are critical for release of urination and of course, in humans and other animals. We have tight control over this and we don’t, you know, we only are supposed to go at appropriate times. And this is very important. And so I don’t know yet how Barrington’s integrates this information, but certainly it must right it It knows when your bladders full, and otherwise you don’t have that kind of urge. So yeah, I think it’d be really interesting to understand in the future, what those neurons are sensing.

Peter 27:51
We have a question from Jorge Villalobos.

Audience 27:54
Hey, I’m Jorge. I’m calling from Duke University. And I have a question for Dr. Zimmer. So Dr. Zimmer, what would happen if you play a recording of ultrasonic vocalizations on one side, then if you have a pup on the other side, would the ultrasonic vocalization would be like a stronger stimuli for the dam to prefer that side? Or would the olfactory cues from the pump would be a stronger signal and then the mother would go to the other side?

Dr. Marcelo Zimmer 28:23
Yeah, that’s a great question. We’ve never done this type of experiment, we try to evaluate whether only playing record user playback system in which we would play the record off of error mode in which we activate the newest compared to animal that is a control animal to see the model prefer one side over the other. And we are not capable of having like a final result, we realize that odor cues are super important. So not only visual cues, because once the mother realizes there is no neonates that are there she stopped, she stopped directing, but there are so we never done that. But if I have to guess I would say the daughter queues and this stage, they will play a higher role will be more important for a preference of the monitors, either the odor queues or the auditory cues.

Peter 29:14
Thank you. And we have another question from Amy Shepard.

Audience 29:18
Yeah, hi, I’m calling from Boston. And my question is for doctors around the USVs. I was wondering if not only does the number of calls change, but just the quality or complexity of those calls change. I’m only really familiar about USVs in adults, which I know have, you know, like a lot of variation. I wonder if you looked at that and those parts as well.

Dr. Marcelo Zimmer 29:38
That is a great question. Yes, we look at and indeed change change the part of the cause the animals they elicit different types of syllables. So in neonates, the list of 11 types of syllables that we know and when we quantify the number of vocalizations, in which syllables we find their activation of these neurons, the indeed increase some of the syllables One that we found was a channel was it was a charity organization. So we are trying to identify whether this has any meaning for the mother and look and talk about the spectral temporal features of the vocalizations, it does have a decrease in the duration, it seems to lead to change the new frequency distribution. So, yes, there’s a change.

Peter 30:20
Thanks for the question on communication, like USVs are ways neonates communicate, and I was wondering, you know, broadly about communication. We don’t communicate with USVs. So I was wondering, how do you think about communicating your work to fields very disparate from your own? How do you think about communicating to form collaborations and communication in general to inform the general public?

Dr. Marcelo Zimmer 30:42
Yeah, that’s not an easy question. What we can try to communicate the general public is that we see the vocalizations of the infants as a form of crying of the animals. So the way that we try to communicate that we are trying to identify one of the most innate behavior that we see not only in mice, but also in humans, which is a crying behavior. So this is the way that we try to communicate for general public our findings.

Dr. Kara Marshall 31:07
It’s kind of weird to study your nation. And I think as a neuroscientist when people say, Oh, you do neuroscience, what do you study? It’s, it’s something that kind of takes people back when you’re like, oh, urination. And it’s because I think societally, it’s not something people talk about, like when again, I was really stunned by the epidemiology. And you can pretty much bet if you’re talking to an older person, they’ve had some issue with their urinary tract. And so I think it’s actually, it’s been really neat to see that by studying these kind of basic functions, it opens the public up to talk about things that maybe they wouldn’t normally talk about, or even honestly, for adults to know that they’re not alone, that this is actually really common, and that they should seek out help for some of these issues, when you know, it’s sort of not not discussed very often. So I would say that, in some ways, urination is great and easy, because everyone does it and really connects to it because it’s a normal part of their lives, and lots of things go wrong. But on the broader scale, I think, for so long, especially in touch research, and like doing very basic science research about ion channels and stuff, it felt disconnected from the public. And I think that what’s been nice is kind of being able to really teach people the importance of just basic science. And I’m sure Dafni has strong feelings about this working in flies, because, I mean, I see the gorgeous, like, whole gut images, like there’s so much you can do in flies. And I think that, you know, conveying to the public that like figuring out these really fundamental questions, like answering fundamental questions is just about, like, how does this system work, even if it’s in, you know, a simpler model organism or something is really just like an important foundation. And I think that it is so critical to convey to the public, like basic science research is how we get to this translational stuff. And, you know, you don’t always know where that will come from. So you have to have a really broad foundation of basic science research in flies, and then, you know, mice.

Dr. Dafni Hadjieconomou 32:59
I do feel like that. And I think, just being in the business for a bit longer, you just sort of know, to filter down the information that you give to people, you know, people just ask yourself, what, what excites you and what are you working on? And you can start by saying, Hey, you know, I worked to understand how the brain works. And so you know, of course, everybody’s kind of interested in the brain. And then people are interested to find out that their neurons in your gut, which you know, and it’s a surprise to a lot of people still and I guess, then if you talk to them and bring it home, that if something doesn’t go really well, with that, you you might have an eating disorder, let’s say so I think you always have to link things, as Kara said, as, for instance, with the older people with something they have experienced and remove the jargon as much as possible. It’s not very easy. I think, if you just get better with the more you do it.

Dr. Yuuki Obata 33:55
Yeah, this is very difficult. But yeah, very important to communicate with the public. So in my experience, I have contributed to make a documentary film about gut physiology in collaboration with TV programs. So they they’re professionals. So we don’t we just provided the concept and the beautiful image of the gut. So that was, that did work very well, in terms of the delivering the message to many people.

Peter 34:24
Just speaking of like, things in the public. One of the things really just coming up to public perception now is the importance of science with the global pandemic that we’re having and coronavirus. What do you think the biggest hurdle or issue that our generation of scientists is up against?

Dr. Marcelo Zimmer 34:41
So I think we are not trained to communicate, so we don’t know how to communicate why we’re doing so that’s why I think we have this, this, this difficulty to talk to people. I mean, we don’t have any training to communicate what we’re doing to show the importance of why we’re doing. I would say for you Peter, it really depends well where you are as well, because I can I can say right now we have the opposite. People still don’t believe in science even more right now, because we have people that don’t think the vaccine is like this the cure for the COVID. So we have two problems in my vision, the first that we don’t know how to communicate. And there’s also political views about science, depending on the country, where you are.

Dr. Kara Marshall 35:20
Yeah, I agree. I mean, I’d say that I feel like in the US, politicians have been pretty good about like, continuing to fund the NIH, for example, even though there might be anti-science rhetoric in general, they kind of come through with some funding. But we need to be better not only about communicating the excitement of science, but just like how beneficial it is, like, I think these advances are so slow, you know, what’s coming on the market now might have been researched 10 years ago, or 15 years ago. And so it’s hard for a person and this is especially true in the private sector to look at this and say, Oh, you know, what you’re doing now is going to definitely economically benefit me and benefit humans. And so I think like, having a better narrative around these processes, and how they are slow, and it takes kind of people coming at questions from all different angles, which takes a lot of money. And I think that showing people that output and like the Human Genome Project was this moonshot. And it was it worked. And it actually like, has generated so much value, not only economically, but also just for knowledges sake, I don’t know, I think there’s like the two pronged argument could be made. So maybe scientists need to be better about communicating that.

Dr. Dafni Hadjieconomou 36:27
Yeah, absolutely. I think, you know, communication is a big thing. But I guess we’re also facing, perhaps an economic crisis I had, and that is going to impact science for sure. Across the board, so some countries will be more or less affected, I guess. So I guess this is where somehow we have to come together. And for more collaborations, perhaps and, and, you know, perhaps think of different ways of doing science, which is very hard, because careers are, you know, need to still be shaped. And it’s a it’s a hard one. But I guess you know, our generation could be perhaps more open. I don’t know, it’s a hard one. I think if I have to just find one that is going to be the most difficult hurdle to overcome. For our generation of scientists, I guess we are quite a lot at the moment, and very excited and the funds are might run thin for a wide base, I mean, or not, we’ll see.

Dr. Kara Marshall 37:27
I was just noticing someone asked about diversity and inclusion. And I was gonna say that one of the plans or hopes that I have in the future is, you know, of course, to have a really inclusive and diverse environment. But I think one of the ways to do this is really make sure that a broad range of undergrads get a chance to be in love. Because I think that’s the time at which most of us get our first experience with research. Like, I didn’t know anything about being a scientist, when I was an undergrad. I mean, I liked science. But I think that just making sure that a broad range of undergraduates that you know, may or may not have been exposed to science at all, like have the chance to go through lab. And what that can do is really allow us to practice mentorship at all the different levels, right, if you have grad students, mentoring undergrads and postdocs, mentoring graduate students, and like making sure that not only is everyone welcome in lab, but also people practice mentoring a diverse set of you know, others, right, and it’ll, you know, maybe people when they’re undergrads decide they don’t like it. But at the very least giving that opportunity and making sure that people from a broad range of backgrounds have the chance to access that is good. The other thing is outreach, I think is really fun. And we had talked about communication. But outreach to local schools is something I’ve always done wherever I am. And that’s also a really great way to introduce kids to the idea that scientists are real people. And it’s a manageable, fun career that you can actually pursue. And it’s not, I think it feels very kind of elitist if you’re not, you know, introduced to a scientist or whatever. So I think that encouraging communication, encouraging your lab members to seek out events where you go to schools and communicate science is a really good opportunity to both increase diversity and inclusion, but also to train people on communication and mentorship. So it’s like two birds with one stone.

Peter 39:07
Yeah, that’s really great. I think that question was from Yeka Aponte. I don’t know if you had a follow up.

Audience 39:12
Yes. I’m very delighted to be here today. I mean, thank you, Diego for inviting me. So I’m Yeka Aponte. I’m a tenure track investigator at the NIH. And Kara, your answer was a stellar because it’s about time that you know, especially when we think about gender, and we think about diversity & inclusion, that’s what he makes us stronger. And I think that we all have to when to reach, you know, the PI level to feel that we have a voice, you know, and that’s something that as you guys all said, no one teaches us how to be a manager we have to learn by doing. And I think that that’s kind of challenging. The other thing is that I recently became the director of the diversity and inclusion at the NIH, NIDA. And, and I think the one of the hardest and more challenging things is that, you know, expectations are really high when we join a lab. Interns, summer students, you know, and you have to understand when you have these kids that come from underrepresented backgrounds, they didn’t have the same privilege that most of us had, and the same training. So you have to put an effort to really, really get these kids to that level. And as Kara very nicely stated it, you have to start from like the undergrad level. I mean, if it were up to me, I would start, you know, for like, elementary school, but at least we have to start somewhere. And I think that this is the advice that I give all the investigators that you know, you have to be patient, you have to understand that perhaps in the first year, you’re going to want to get any data from that student, but the reward that you’re going to get one, that kid that perhaps is the first generation going to high school and college came out of your lab, you will feel so proud. I said, that’s my child, you know, that kid became a doctor because of me, because the training in my lab, so on a team that, you know, it’s about time that we educate ourselves about our conscious and unconscious biases, because we all have them, even if we don’t know. And, you know, this is something that, you know, I tell my lab members, we have to stop being bystanders, and you know, speak out & loud. I mean, I’m sure you’re all aware about this horrible paper that came out two weeks ago, and how female scientists not being good mentors, you know, I mean, on top of dealing with my background as diverse, I also have to deal with my agenda just to show people that yes, I can be a good mentor. It has nothing to do with my gender. So yeah, those are the comments that I just wanted to ask. But thank you, Kara, for just stating this at the level of you know, the trainees. So it was really enlightening for me to hear that.

Peter 41:37
Yeah, I don’t know if there’s any better way to close than that. I feel very empowered. I feel like we have to keep pushing the ball forward. We have to continue advancing science. And I really wanted to thank everyone here for coming to this Gastronauts Bite Size Summit. We really enjoyed your presence and we really valued your opinion. Thank you all so much for listening! Science is all about this open communication and how we can continue to advance it. If you can think of any other ways for how Gastronauts can improve, please feel free to reach out to us. If you feel like you’ve got something from this today, we’d love if you’d share this with a friend or a colleague and just get more people in the know-how about Gastronauts and about science. Thank you so much for joining us and thanks so much to our speakers.

Peter 42:48
Thank you all so much for listening and we’ll see you on our next episode. For more of our content, you can follow us on Twitter @gutbrains or visit our website at thinkgastronauts.com. The Gastronauts Podcast would be impossible without our incredible team. Meredith Schmehl is our producer and theme music composer, and special thanks to the founders of Gastronauts: Dr. Diego Bohórquez and the Bohórquez laboratory.

Episode 17: What Bugs Us

Peter 0:15
Hi, welcome back to the Gastronauts podcast. My name is Peter. And my name is Reem Hasnah, and we’ll be your hosts. Here at Gastronauts, we are committed to exploring communication throughout the body with a focus on the crosstalk between gut and brain. We invite speakers in this field to share both their research and their life journeys. So come join me as we explore the steps that go into shaping a scientist on the Gastronauts Podcast. Today, we have two great scientists Dr. Mary Estes and Dr. Dylan Dodd.

Reem 1:06
Dr. Mary Estes is a professor of biology and microbiology in the Department of Medicine at Baylor College of Medicine. She’s a member of the National Academy of Science, the past president of the American Society for biology, a fellow of the American Association of the advancement of science, and has authored over 400 articles. She’s a molecular biologist whose research is focused on understanding viral infections of the gastrointestinal tract. Her research group focus is to study how the viral proteins interact with receptors of the intestinal cells. Welcome, Dr. Mary.

Dr. Mary Estes 1:41
Thank you very much.

Peter 1:42
Dr. Dylan Dodd is an assistant professor at Stanford University. He received his training as a physician scientist at the University of Illinois in Urbana Champaign. his PhD work was done in Professor Isaac Khan’s laboratory, where he looked at the molecular mechanisms that were involved in how energy is captured by gut bacteria. And then he worked in Dr. Sonnenberg laboratory where he studied how gut bacteria contribute to small molecules that impact host physiology. He has leveraged his research to co found a company that engineers bacteria to modulate the immune system. And his research group’s focus is to uncover the chemistry underlying host microbe interactions in the gut.

Reem 2:24
Dr. Mary and Dr. Dylan. So what was the motivation behind you both going into research and studying these microorganisms like the microbiome and the viruses?

Dr. Mary Estes 2:36
So I originally had thought that I would go to medical school because I didn’t know that there were was another career that you could do research. And when I went to undergraduate college at a small girl school, we had a visiting prior graduate from the college come and give a talk. She was doing research in microbiology, and I had liked biology, I thought that I wanted to do immunology and I suddenly discovered that there was this whole other area of research. So I applied to graduate school. And then when I took my first class in microbiology, I learned about viruses. And I was hooked from then on. I worked on different viruses, tumor viruses initially, and then once I came to Baylor, I still worked on tumor viruses for a while, and then changed into gastrointestinal viruses after a few years.

Reem 3:27
So the carrier started with a spark.

Dr. Mary Estes 3:29
Yes.

Reem 3:32
Yeah. And you Dr. Dylan?

Dr. Dylan Dodd 3:34
Yeah. So I also was very excited about immunology, I actually joined MD PhD program straight out of undergraduate, because I knew I wanted to try to do science that could more broadly impact patient health. Unfortunately, you know, as graduate school goes, sometimes the lab you wanted to go to, there aren’t openings. And so I ended up going to microbiology, which I had never even studied as an undergrad. And I was captivated by it actually worked on trying to identify new enzymes for biofuels, if you could imagine, and the best place to look for enzymes that break down grass and lignocellulose is really the cows for stomach, the rumen. And so I did my PhD in rumen. microbiology. And it was very surprising for a lot of people that were my cohort and MD PhD. They said, Why are you studying the cow, but I immediately made connections between the metabolic activities within the cow’s stomach and what’s happening in our gastrointestinal tract. And so then I switched over to studying human colonic microbiota and their metabolic properties.

Peter 4:46
That’s super neat. It’s just so interesting how people get into their path into science and there’s just so many different paths to it. I guess for me, I had never thought I’d be studying the gut either. I never thought I’d be working on a podcast or the session with Reem. So I think it’s All about that spark.

Reem 5:02
It’s a small world Peter.

Peter 5:05
We’re really excited about the audience being really interested in asking questions. And we are going to start having people in the audience who have typed their questions ask their question,

Reem 5:15
Dr. McCann.

Dr. McCann 5:17
My question is for Dr. Dodd. I’m a research staff scientist in the Rawls lab. And we’re also really interested in microbial metabolism along the gut. And I was just curious actually what you thought about your sample set diversity. I know the Sonnenberg lab has access to tons of diversity as far as fecal samples go, but for your blood metabolites. I know, for instance, we have a hard time in really finding diverse populations and sample sets to look at for microbial metabolites. And I was curious about what you thought about that access? And how important it is?

Dr. Dylan Dodd 5:51
Yeah, thanks. That’s a great question. And I fully admit that our sample is not really capturing great diversity. It’s just capturing sort of the cultural background of the Bay Area, and especially tech companies. And in fact, we don’t have the metadata to say what the background is, or do we have any information on diet? So yeah, as you mentioned, you know, Justin Sonnenberg also at Stanford, in fact, my former mentor, has been studying the hodza, which is a sort of hunter gatherer population. And he’s got extensive metabolomics data that he’s working on in different populations across the world. And, you know, I think he definitely sees large changes in metabolomic profiles that vary across people. And so I think it’ll be really interesting as we start to build up datasets from culturally diverse as well as geographically diverse, as well as people taking diverse diets.

Dr. McCann 6:54
Thanks.

Peter 6:54
With regards to the diversity is that we experienced with our diverse diets and what not married, are you aware of how this diversity affects infections to viral gastroenteritis?

Dr. Mary Estes 7:06
I actually don’t know the answer to that question. Maybe there’s another a bile acid person that studies that this more broadly in different populations, or Victoria, do you have an answer?

Victoria 7:18
I think we’ve had this question, at least with individuals who have deficiencies in bile acid production. They’re more or less susceptible, but I don’t think we have an answer

Peter 7:28
Moving on, we have actually a question from Roy.

Roy 7:32
Hi, Dr. Dodd. I’m a student in Dr. Mary Estes lab, also joining us today. So I was wondering, my question is short, so I was wondering if the caffeine level you’ve just mentioned is now indulgence, right? So [I was wondering] you have some topic to say related to coffee or tea consumption and how affects maybe metabolite composition?

Dr. Dylan Dodd 7:58
Yeah, so I didn’t even mention it. I had caffeine on the far right of my plot of metabolites. And, you know, one, one point I like to make about that is actually 25% of individuals in our population had undetectable levels of caffeine. And that corresponds roughly to the caffeine consumption that we know, for, you know, typical individuals in the population. So 75% of people were positive, and then their concentrations ranged about as dramatically as the microbial metabolites. And so I just like to make that comparison to orient people and then also to say that, you know, that microbial metabolites are drug like molecules, essentially similar to caffeine. And their concentrations are varying as much in the population.

Roy 8:43
And may i ask one more question. So you just mentioned that there’s some potential limitations in metabolomics. So I’m wondering, are people developing a new technique to try to detect all undetectable metabolites so far, or that technique is improving?

Dr. Dylan Dodd 9:02
Yeah, that’s an important question. And, you know, if you look at, say, David Wishart’s group, who has the human metabolome database, you know, when they publish their papers, they go extensively into their samples with multiple different methodologies. And they may get very trace molecules that we would be unable to detect. So, you know, we’re, I do believe that we’re just kind of scraping the surface. But you know, mass spectrometers are sort of the workhorse of metabolomics. They have linear dynamic range on the order of four to five orders of magnitude. So I think it’s a really good approach right now, but I’m sure as we get interested in molecules that are at lower concentrations, we’ll have to change our methodology.

Roy 9:48
Okay, thank you.

Reem 9:49
So people are subjected to several medication and several foods and nutrients. And so how do you establish a stable set of microbial metabolites And how are they altered by pharmacological intervention? So what do you think?

Dr. Dylan Dodd 10:06
Yeah, that’s that’s a great question. It’s such a complex microbial community. And production of these molecules isn’t linear. It’s not one microbe acting on its own to produce these chemicals. It’s the microbial community interacting, exchanging electrons, transferring substrates. And so really, it’s, it’s incredibly challenging to tell how a dietary perturbation is actually going to influence a molecule like an amino acid metabolite. If you give fiber to people, you might actually see an increase in some of these protein metabolites. And it’s really difficult to understand. So I think to get at that, what we really need to start doing is human studies that are, you know, essentially longitudinal, studying each individual and how their metabolism changes over the course of a day over the course of different diets. And if we were able to do large scale studies of those sort of longitudinal analyses, I think we’ll learn an incredible amount about how diet influences microbial metabolites.

Reem 11:12
Yeah, that’s great. What do you believe is the most critical lack in our understanding of the host microbe interaction, to help us get into the precision of us having transplanted microbiome and then getting over specific diseases?

Dr. Dylan Dodd 11:30
Well, I mean, in the in the context of therapeutics, we don’t really know what dictates whether a microbial community will stay after transplantation. So it’s community dynamics, that really we don’t understand. We know that if you do a fecal microbiome transplant, you can actually track donor strains. And you can also track the original strains from the recipient. And you get some sort of mixture of that as assemblage over time. And so I just think that it’s going to be more of these very careful, multi omic types of analyses of FMT, that is going to allow us to understand more about the mechanisms and the dynamics of microbial interventions at the community scale.

Dr. Mary Estes 12:17
I think that what you said is absolutely true. I think the other big challenge at the moment is having technologies to be able to really address host micro biome interactions. I mean, one of the ways we’re doing that is with these cultures, we can put the cultures in anaerobic chambers, and we’re now making platforms or we can add the microbiota. And we do have a few examples. Now we’re putting microbiota in with a virus. microbiota can enhance viral replication, or in other cases where it can reduce viral replication. Now, that’s all in vitro, it’s reductionist, but that may be a way to that to begin to understand some of these more complex communities, perhaps in a simpler system. And then you would certainly have to go back ultimately and tested in animal models or perhaps people

Peter 13:08
Really neat. Andrea Marciniak.

Andrea 13:11
Yes. Hi, I’m a graduate student from the University of Virginia. And I had a quick question for Dr. Dodd, I’m actually studying how microbial metabolites are impacting the CNS. And have been thinking about this question a lot recently, of how likely is it that we will be able to modulate microbial communities long term to mediate their metabolism in chronic disorders? So I’m thinking things like, you know, depression or mood disorders? And is it likely that our work might be used in the future just for drug discovery? And that will actually be using these small molecules in a pill form?

Dr. Dylan Dodd 13:45
Yeah, I think if you look at sort of the biotech space, you know, they’re very much used to working on small molecules. But having biological entities like a microbe that’s anaerobic, and its entire suite of pathways, as well as its interactions with other strains, is really challenging to conceptualize and to bring through sort of the market. So I think the low hanging fruit are the small molecules that have specific receptors that you can actually dose. But a lot of the case in the microbiome is you want to actually deplete some molecules that potentially have a deleterious effect. And in that case, you might be able to block the receptor. But another strategy would be to make a fecal microbiome transplant, if you will, and potentially a synthetic FMT to actually replace the microbes in the community with ones that don’t produce that molecule or take the molecule the substrate down a different pathway. So there’s a lot of approaches people are taking, and I think all of the ones I’ve described, at least a few companies are working on. And so it’ll be super exciting to see what ends up working. And the the nice idea about the fecal microbiome transplant is you could potentially affect a long term change, if you could replace somebody’s microbiome with a synthetic community, but that has yet to be shown to be possible.

Andrea 15:31
Okay.

Maya 15:31
so my name is Maya Kaelberer. I’m here at Duke University. So we care a lot about good bacteria and bad viruses, if I’m going to generalize. What about good viruses? Are there symbiotic viruses that are symbiotic with like, maybe even the host, the human or even the bacteria? And how is their role different than bacteria? Or is it similar?

Dr. Mary Estes 15:53
I’ll give you two comments about good viruses. One are viruses that infect plants. So the tulips that you enjoy in the spring, and if you go to the Netherlands, there will actually be production facilities, in a greenhouse where a particular plant virus is added to make the white stripes on a red tulip or something. So that’s one example of a really good virus, I think.

Maya 16:18
Beautiful virus, yes.

Dr. Mary Estes 16:21
The other area where people are looking carefully now our bacteria are phage that actually come from infecting bacteria. But they may have some positive effects in the intestine. They’re not fully understood yet. But there’s some suggestion that the levels of phage may be important in outcomes of colitis. I think some of that is from animal models. I don’t know that we have good data in people yet. But I think that’s an area that’s going to be looked at, like carefully and there are beginning to be more and more stories where there are interactions between hosts genetics, bacteria and viruses that can either make disease worse, or trying to they I don’t know that I know of one that’s potentially better, but I think we’ll learn about those in the future.

Dr. Dylan Dodd 17:09
Are you interested in the bad bacteria?

Maya 17:14
I guess that’s true. My, my question was very one sided. But what about the bad bacteria?

Dr. Dylan Dodd 17:20
Yeah, I mean, we like to think a lot about beneficial microbes. And there are a lot of them, but not all microbes are commensals. And I mean, there’s opportunistic pathogens, which we know a lot about, especially esbl, for immunocompromised individuals, that can lead to enteric and systemic infections. But I think, you know, as we learn more about microbial metabolites, there are contexts where those molecules and their signaling pathways are beneficial. And there’s contexts where the same molecule on signaling pathway could actually be detrimental. And I think as we learn more about those specific interactions, we’ll learn about you know, what is sort of a beneficial context and one patient population versus another.

Dr. Mary Estes 18:04
I do know, so there are people in Houston that are studying Cryptosporidium, they also had done volunteer studies, and they had found that the levels of indle in the large intestine actually seemed to protect against crypto infection there are now doing experiments to try to understand exactly how that’s working. But that would be potentially an example where if you had the right bacteria making that you might be resistant to an infection.

Reem 18:33
We have a follow up question.

Elaine 18:35
hi. This is the Elaine Snell from England, London, about to go into lockdown. Question for Mary. So thank you and thank you both actually for your excellent presentations. I really enjoyed them. And Mary, I was immediately struck by the fact that you were talking about norovirus as a pandemic, the G 242 three strains that cause a pandemic that that norovirus kills 200,000 people globally every year. Well, you know, in the current circumstances, with Coronavirus, claiming all the attention whilst I’m not asking you a political question about how it’s been dealt with, I mean, you must have a view on you know, the the ways that norovirus is communicated and managed and lessons that can be learned for, you know, this other virus Coronavirus that also kills hundreds of thousands of people this year, I can imagine it must be quite frustrating for you to see the way it’s being managed in many respects, but I don’t want to put words in

Dr. Mary Estes 19:42
I mean, I think we know how to manage it. The question is whether the population will until we have a vaccine or prevented therapeutics. You know, you need to wear masks social distance. Wash your hands and actually those are the same Same rules for norovirus. So this is a virus that used to be known as the cruise ship virus. I think maybe that’s now taken over by our new pandemic Coronavirus. But it’s the same principles. When you get people in closed semi closed environments. You may have one person come on a cruise ship that’s sick. And if they don’t use good personal hygiene and go around touching surfaces, this is fecal oral spread. They’ll spread the virus very readily and you and you can have thousands of people on a cruise ship that will get sick with this. There have been ships that have been denied entry into ports in the last several years, because so many people are infected. So the principles are the same. I hope that if people will become educated about infectious agents, and how do you handle them, really probably could reduce the level of infection globally for many of these organisms. I mean, even the Coronavirus seems to be having an enteric phase and many people, it’s not clear that it’s actually spread through the feces but it certainly can infect the intestine. There’s been some suggestion that it may cause a pro inflammatory response in the intestine that may actually get into the circulation and affect other organs. That’s not fully proven, but as a hypothesis.

Elaine 21:23
Thank you.

Peter 21:24
Yeah, this is just having me think Reem and I were having a discussion earlier. I think every time before we have our meetings, we talk about how is COVID affected you? Are you doing okay in the time of Coronavirus? I was wondering, a lot of times these research in norovirusi and I guess research in the microbiome is not quite made it to the same degree of the public as Coronavirus has, and I was wondering how do you apply these findings from your research into your personal your day to day lives?

Dr. Mary Estes 21:49
I try to use good personal hygiene to prevent getting the infections and I think in terms of in the era that we’re in with Coronavirus. I think we’re trying to apply all the expertise that we have to maybe trying to answer a question about Coronavirus. So there’s been a lot of discussion about whether Abo blood type may be important or Coronavirus, infections. And there’s you’ll read one report that says that there is another that says it isn’t we have actually submitted a proposal to try to look at that, using our culture’s were so the histo blood group antigens are part of the Abo blood type system. And we have these cultures now that we’ve well characterized, we know what kinds of glycans are on them. And we’re proposing to try and use them to infect with Coronavirus to see if in the in vitro system, we can actually get a clear answer. And if we can to determine what part of the spike protein might be binding to the glycan where it might be binding and see if that might be able to be blocked in some way.

Dr. Dylan Dodd 22:55
Yeah, I can chime in on you know, how we use the microbiome and the metabolites that we’re studying in our day to day lives. You know, I have a six year old, and my wife and I, you know, are conscious about what we eat, and especially coming from Justin Sonnenberg lab, we have a copy of the good gut, on our shelves. And so we incorporate we try to incorporate more fiber into our diet. He’s a huge proponent of that. And there’s a lot of evidence that increasing your fiber intake is beneficial. We actually have a lot of fun picking that recipes randomly from the book. So I encourage you to take a look at it if you haven’t seen it already. It’s just a lot of fun. Justin and Erica Sonnenberg have done an amazing job with that.

Peter 23:36
I feel like the research that we do just definitely lends itself to, you know, impacting our personal life, especially if we study the gut, or viruses that infect our gut or viruses in general means basically like our understanding of our personal hygiene, how we live our daily lives-

Reem 23:52
and also the decisions we make on a daily basis. So whatever we learned in the lab, actually influenced our decisions in the future. I would like to thank our amazing audience who without them, we wouldn’t have this great discussion or these questions. Also a huge thank you from the Gastronauts family, to our guests, Dr. Mary Estes and Dr. Dylan Dodd, thank you for your precious time, and for taking part of today’s discussion.

Dr. Mary Estes 24:16
Thank you for inviting us. It was great to be here.

Dr. Dylan Dodd 24:19
Thank you so much.

Reem 24:33
Today we had a great episode, and a great discussion. And we knew that our body is far more complex than what we expect or know. Thank you all for listening. And we’ll see you on the next episode. We are really excited to announce that Gastronauts Global will take place this year and will start May 11! See you all in the virtual Gastronauts global. For more of our content, you can follow us on Twitter @gutbrainmatters or visit at our website thinkgastronauts.com. The Gastronauts Podcast would be impossible without our incredible team. Meredith Schmehl, our producer and theme music composer, and a special thanks to the founder of Gastronauts: Dr. Diego Bohórquez & the Bohórquez laboratory.